247 related articles for article (PubMed ID: 38526142)
1. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
[TBL] [Abstract][Full Text] [Related]
2. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
Khong E; Oh J; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
bioRxiv; 2023 Aug; ():. PubMed ID: 37662290
[TBL] [Abstract][Full Text] [Related]
3. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
[TBL] [Abstract][Full Text] [Related]
4. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong T; Salabarria AC; Roach DR
Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
[TBL] [Abstract][Full Text] [Related]
5. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage and antibiotic combination therapy for recurrent
Stellfox ME; Fernandes C; Shields RK; Haidar G; Hughes Kramer K; Dembinski E; Mangalea MR; Arya G; Canfield GS; Duerkop BA; Van Tyne D
mBio; 2024 Mar; 15(3):e0339623. PubMed ID: 38353560
[TBL] [Abstract][Full Text] [Related]
7. Phage therapy for respiratory infections.
Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
[TBL] [Abstract][Full Text] [Related]
8. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
Tagliaferri TL; Jansen M; Horz HP
Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
[TBL] [Abstract][Full Text] [Related]
10. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.
Al-Anany AM; Fatima R; Nair G; Mayol JT; Hynes AP
mBio; 2024 Jun; 15(6):e0050424. PubMed ID: 38757974
[TBL] [Abstract][Full Text] [Related]
11. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary Rationale for Phages as Complements of Antibiotics.
Torres-Barceló C; Hochberg ME
Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
[TBL] [Abstract][Full Text] [Related]
13. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
Segall AM; Roach DR; Strathdee SA
Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
Malik S; Nehra K; Rana JS
Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
[TBL] [Abstract][Full Text] [Related]
15. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
[TBL] [Abstract][Full Text] [Related]
16. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
Mangalea MR; Duerkop BA
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
[TBL] [Abstract][Full Text] [Related]
17. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects of Phage-Antibiotic Combinations against
Manohar P; Madurantakam Royam M; Loh B; Bozdogan B; Nachimuthu R; Leptihn S
ACS Infect Dis; 2022 Jan; 8(1):59-65. PubMed ID: 34979073
[TBL] [Abstract][Full Text] [Related]
19. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
Torres-Barceló C
Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
[TBL] [Abstract][Full Text] [Related]
20. Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy.
Azam AH; Sato K; Miyanaga K; Nakamura T; Ojima S; Kondo K; Tamura A; Yamashita W; Tanji Y; Kiga K
Microbiol Spectr; 2024 Jun; 12(6):e0042723. PubMed ID: 38695573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
